Potential mortality benefit from secondary prophylaxis following CMV treatment completion may be due to confounding by transplant organ type
Keyword(s):
2021 ◽
Vol 116
(1)
◽
pp. S606-S608
1995 ◽
Vol 53
◽
pp. 682-683
Keyword(s):
1993 ◽
Vol 89
(2)
◽
pp. 315-322
◽
Keyword(s):